This week's View focuses again on the COVID-19 resources on ACC.org, featuring articles on the association between the use of antihypertensive medications and the likelihood of a positive test for COVID-19 and likelihood of severe COVID-19, the association between the use of renin-angiotensin-aldosterone system blockers and the risk of COVID-19, and the association of climate with the spread of COVID-19 infection, as well as key points to remember from an American Society of Echocardiography statement on protection of patients and providers during echocardiographic exams during the COVID-19 pandemic.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: COVID-19 Hub, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Prevention, Acute Heart Failure, Computed Tomography, Echocardiography/Ultrasound, Magnetic Resonance Imaging, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Type 2 Receptor Blockers, Antihypertensive Agents, Calcium Channel Blockers, Cardiovascular Diseases, Climate, Coronavirus, severe acute respiratory syndrome coronavirus 2, COVID-19, ACC COVID-19 Podcast, Diagnostic Imaging, Disinfectants, Echocardiography, Echocardiography, Stress, Echocardiography, Transesophageal, Humidity, Hypertension, Intensive Care, Magnetic Resonance Imaging, Peptidyl-Dipeptidase A, Personal Protective Equipment, Population Density, Pregnancy, Primary Prevention, Public Health, Renin-Angiotensin System, Respiratory Protective Devices, Risk Assessment, SARS Virus, Seasons, Secondary Prevention, Sodium Chloride Symporter Inhibitors, Temperature, Tomography, X-Ray Computed, Ultrasonography, Vascular Diseases, Ventilators, Mechanical, Weather, Heart Failure

< Back to Listings